Standout Papers

Urine TMPRSS2:ERG Plus PCA3 for Individualized Prostate Cancer Risk Assessment 2015 2026 2018 2022 264
  1. Urine TMPRSS2:ERG Plus PCA3 for Individualized Prostate Cancer Risk Assessment (2015)
    Scott A. Tomlins, John Day et al. European Urology

Immediate Impact

2 by Nobel laureates 3 from Science/Nature 54 standout
Sub-graph 1 of 22

Citing Papers

Renal Cell Carcinoma
2024 Standout
Small and long non-coding RNAs: Past, present, and future
2024 Standout
2 intermediate papers

Works of Daniel H. Hovelson being referenced

A distinctive, low‐grade oncocytic fumarate hydratase‐deficient renal cell carcinoma, morphologically reminiscent of succinate dehydrogenase‐deficient renal cell carcinoma
2017
Urine TMPRSS2:ERG Plus PCA3 for Individualized Prostate Cancer Risk Assessment
2015 Standout

Author Peers

Author Last Decade Papers Cites
Daniel H. Hovelson 514 416 376 479 441 45 1.6k
Kim Ely 440 696 371 457 578 51 1.9k
Idris Tolgay Ocal 253 340 368 404 407 53 1.5k
Omar Hameed 637 437 435 347 578 81 1.7k
Francisco J. Martínez‐Tello 354 537 199 275 477 42 1.6k
Nicole Massoll 241 498 216 461 348 41 1.7k
Isabelle Soubeyran 519 334 365 239 823 69 1.7k
Antonio Cavaliere 346 717 372 343 718 71 2.2k
Renê Gerhard 240 605 352 366 960 41 1.7k
G Juillard 375 176 201 504 585 63 1.7k
Barry R. DeYoung 365 458 233 313 551 57 1.7k

All Works

Loading papers...

Rankless by CCL
2026